Assessment on Diarrhoea and its Herbal Remedy with Ficus Tree
Abstract
Diarrhoea is defined as an abnormal frequent discharge from the bowel (more than 3 times a day) and a semisolid or fluid consistency of the faecal matter which is result of the disturbances of enteric water, electrolytes balance and increased intestinal motility. There is a wide array of causes and pathological mechanism which resulting acute, chronic and persistent forms of diarrhoea. In present scenario, corona virus has also become one of the causes for resulting diarrhoea. To treat diarrhoea, varieties of synthetic drugs are available but there is a risk of unwanted adverse effect. Expenses associated with the use of traditional medicine have generated recommence interest and reliance on indigenous medicinal plant in the treatment and management of diarrhoeal infections. Various phytochemical constituents found in plants are useful in the treatment of Diarrhoea have to be screen for their valuable information. Among these one of the plants used for treatment of Diarrhoea is Ficus glomerata because of the presence of Alkaloids, Tannins, Flavonoids, Terpenes, Saponins and Phenolic compound.
How to cite this article: Sharma S, Kumar A, Singh P et al. Assessment on Diarrhoea and its Herbal Remedy with Ficus Tree. J Durg Dis Dev 2021; 5(1): 1-3.
DOI: https://doi.org/10.24321/2581.6861.202101
References
Gerok W. Pathophysiology of chronic diarrhoea. Praxis (Bern 1994) 2000; 89(41): 1635-41.
Corinaldesi R, Stanghellini V, Barbara G et al. Clinical approached to diarrhoea. Intern Emerg Med. 2012; 7 Suppl 3: S255-62.
Liang W, Rao S, Xiao C, et al.Diarrhoea may be underestimated: a missing link in 2019 novel
coronavirus.Gut 2020; 69(6): 1141-1143.
Abraham B, Sellin JH. Drug-induced diarrhea. Curr Gastroenterol 2007; 9(5): 365-372.
Gracey M. Bacterial diarrhoea. Clin Gastroenterol 1986; 15(1): 21-37.
Bruckstein AH. Acute diarrhoea.Am Fam Physician 1988; 38(4): 217-28.
Vila J. New molecular diagnostic tools in traveler’s diarrhea. Journal of Travel Medicine 2017; 24(1): S23-8.
Huang S, Lin Y, Tsai M et al. Detection of common diarrhea-Causing pathogens in Northern Taiwan by multiplex polymerase chain reaction. Medicine (Baltimore) 2018; 97(23): e11006.
GBD 2016 Diarrhoeal Disease Collaborators. Estimate of global, regional and national morbidity, mortality, and etiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis 2018; 18(11): 1211-1228.
Lakshminarayanan S, Jayalakshmy R. Diarrheal diseases among children in India: Current scenario and future perspectives. Journal of Natural Science, Biology and Medicine 2015; 6(1): 24-8.
Haricharan KR, Shrinivasa BM, Kumari V. Clinical and bacteriological study of acute diarrhoea in children. Indian J Pediatr 2013; 2(23): 4229-37.
Kow CA, Hasan SS. The use of antimotility drugs in COVID-19 associated diarrhea. J Infect 2021; 82(2): e19.
Tripathi KD. A Textbook of essentials of medical pharmacology. Seventh edition, 2013.
Ahmed F, Urooj A. Traditional uses, medicinal properties and pharmacology of Ficus racemosa: A review. Pharm Biol. 2010; 48(6): 672-81.
Liu C, Zheng Y, Xu W,et al. Rhubarb tannins extract inhibits the expression of aquaporins 2 and 3 in magnesium sulphate-induced diarrhoea model. BioMed Research International, 2014.
Begum A, Begum R, Wajid MA. Polyherbalformulation to treat diarrhoea. Int. J. Pharm. Sci. Rev. Res. 2019; 22: 125-30.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
